GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Apr 2018 01:47 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:36 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:30 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:24 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:20 PM
RNS
Director/PDMR Shareholding
13 Apr 2018 03:50 PM
RNS
Director/PDMR Shareholding
13 Apr 2018 03:44 PM
RNS
Director/PDMR Shareholding
13 Apr 2018 11:32 AM
RNS
Notice of GM
12 Apr 2018 03:04 PM
RNS
Director/PDMR Shareholding
03 Apr 2018 04:14 PM
RNS
Total Voting Rights
29 Mar 2018 01:00 PM
RNS
Notice of AGM
27 Mar 2018 07:00 AM
RNS
GSK agrees to acquire CH business from Novartis
23 Mar 2018 11:21 AM
RNS
ViiV - CHMP positive opinion for Juluca in Europe
23 Mar 2018 07:44 AM
RNS
Update regarding Pfizer Inc. Consumer Healthcare
23 Mar 2018 07:00 AM
RNS
Shingrix approved in Europe and Japan
19 Mar 2018 07:00 AM
RNS
GSK 2017 Form 20-F
13 Mar 2018 02:10 PM
RNS
Annual Financial Report
12 Mar 2018 04:30 PM
RNS
Director/PDMR Shareholding
08 Mar 2018 08:00 AM
RNS
GSK announces labelling update to Relvar Ellipta
05 Mar 2018 05:01 PM
RNS
ViiV Healthcare announces new dolutegravir data
05 Mar 2018 02:47 PM
RNS
Nucala OSMO study presented at AAAAI-WAO congress
05 Mar 2018 12:04 PM
RNS
Director/PDMR Shareholding
02 Mar 2018 01:11 PM
RNS
Director/PDMR Shareholding
01 Mar 2018 11:16 AM
RNS
Total Voting Rights
22 Feb 2018 04:54 PM
RNS
Director/PDMR Shareholding
20 Feb 2018 01:17 PM
RNS
Director/PDMR Shareholding
20 Feb 2018 01:16 PM
RNS
Director/PDMR Shareholding
20 Feb 2018 01:15 PM
RNS
Director/PDMR Shareholding
19 Feb 2018 06:12 PM
RNS
Director/PDMR Shareholding
16 Feb 2018 05:29 PM
RNS
Director/PDMR Shareholding
16 Feb 2018 05:25 PM
RNS
Director/PDMR Shareholding
16 Feb 2018 11:20 AM
RNS
Director/PDMR Shareholding
15 Feb 2018 06:09 PM
RNS
Director/PDMR Shareholding
15 Feb 2018 05:57 PM
RNS
Director/PDMR Shareholding
15 Feb 2018 05:53 PM
RNS
Director/PDMR Shareholding
14 Feb 2018 09:00 AM
RNS
GSK submits landmark IMPACT data - Trelegy Ellipta
13 Feb 2018 04:44 PM
RNS
Director/PDMR Shareholding
12 Feb 2018 02:43 PM
RNS
Director/PDMR Shareholding
12 Feb 2018 12:47 PM
RNS
Director/PDMR Shareholding
08 Feb 2018 09:31 AM
RNS
ViiV Healthcare launches new two-drug HIV study
08 Feb 2018 07:00 AM
RNS
ViiV files patent infringement litigation
07 Feb 2018 01:19 PM
RNS
Director/PDMR Shareholding
07 Feb 2018 12:01 PM
RNS
Final Results
07 Feb 2018 09:04 AM
RNS
GSK's Bexsero FDA Breakthrough Therapy Designation
01 Feb 2018 11:52 AM
RNS
Total Voting Rights
26 Jan 2018 12:30 PM
RNS
GSK's Shingrix - positive CHMP opinion in Europe
26 Jan 2018 09:00 AM
RNS
GSK's Relvar Ellipta - positive CHMP opinion
23 Jan 2018 03:22 PM
RNS
Director/PDMR Shareholding
19 Jan 2018 05:19 PM
RNS
Director/PDMR Shareholding
19 Jan 2018 05:17 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings